RENEE BUCHANAN: Open Payments
NPI 1245226802 · FOX RIVER GROVE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$581 in 25 payments from 12 companies in 2025. Trend: 2023 $368 · 2024 $532 · 2025 $581
Food & beverage: $581
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $216 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| GlaxoSmithKline, LLC. | 3 | $52 |
| Novo Nordisk Inc | 2 | $46 |
| Amgen Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $24 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Medtronic, Inc. | 1 | $22 |
Products named: ZEPBOUND, FARXIGA, TRELEGY ELLIPTA, JARDIANCE, Rybelsus, KRYSTEXXA, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across IL — which companies pay providers there.
